Inactive

The Orlando Veterans Affairs Healthcare System intends to solicit and award an acquisition for ThyroSeq: Thyroid Cancer Test. The performance period for this contract will date of award to date of com... The Orlando Veterans Affairs Healthcare System intends to solicit and award an acquisition for ThyroSeq: Thyroid Cancer Test. The performance period for this contract will date of award to date of completion. The Primary North American Industry Classification System (NAICS) for this acquisition is 621511, with a related small business size standard of $35 Million. The proposed action is for Firm-Fixed Price (FFP) requirement contract, which will be advertised as Unrestricted-other than small business. The solicitation will be posted on or about 11 December 2020, via beta.sam.gov website. The solicitation and incorporated provisions and clauses are those in effect through Federal Acquisition Circular 2021-02 11/23/2020. It is the responsibility of the quoter to review the web page for notice of amendments, updates, or changes to the solicitation. No hard copies will be mailed. To be eligible for award, prospective offerors must be registered in the System for Award Management (SAM) Internet site, www.sam.gov. For further information, please contact Jessica Kiser, Contract Specialist at Jessica.Kiser@va.gov. ALL RESPONSES ARE DUE VIA EMAIL TO JESSICA.KISER@VA.GOV BY DECEMBER 18, 2020, 12:00 PM, EASTERN STANDARD TIME (EST). ALL QUESTIONS IN REFERENCE TO THIS SOLICITATION ARE DUE NO LATER THAN 12:00 PM EST, ON DECEMBER 16, 2020 VIA EMAIL TO: JESSICA.KISER@VA.GOV